Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neuropace Inc (NPCE) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neuropace Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1528287.
Total stock buying since 2021: $25,695,014.
Total stock sales since 2021: $64,915,974.
Total stock option exercises since 2021: $2,728.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 5,520,815 | $53,344,135 | 0 | $0 |
| 2024 | 0 | $0 | 952,825 | $10,976,734 | 102,810 | $2,673 |
| 2023 | 0 | $0 | 62,789 | $569,579 | 0 | $0 |
| 2022 | 390,291 | $585,045 | 3,970 | $25,526 | 2,196 | $55 |
| 2021 | 1,477,057 | $25,109,969 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 0 | $0 | 168,136 | $2,670,840 | 0 | $0 |
| 2025-02 | 0 | $0 | 5,349,179 | $50,620,763 | 0 | $0 |
| 2025-01 | 0 | $0 | 3,500 | $52,532 | 0 | $0 |
| 2024-10 | 0 | $0 | 291,969 | $1,662,898 | 0 | $0 |
| 2024-09 | 0 | $0 | 26,645 | $181,780 | 0 | $0 |
| 2024-08 | 0 | $0 | 4,314 | $33,476 | 0 | $0 |
| 2024-05 | 0 | $0 | 29,206 | $409,425 | 0 | $0 |
| 2024-04 | 0 | $0 | 568,426 | $8,202,358 | 0 | $0 |
| 2024-02 | 0 | $0 | 18,252 | $275,369 | 50,000 | $1,300 |
| 2024-01 | 0 | $0 | 14,013 | $211,428 | 52,810 | $1,373 |
| 2023-12 | 0 | $0 | 30,378 | $281,435 | 0 | $0 |
| 2023-11 | 0 | $0 | 24,097 | $212,695 | 0 | $0 |
| 2023-10 | 0 | $0 | 8,314 | $75,449 | 0 | $0 |
| 2022-11 | 390,291 | $585,045 | 0 | $0 | 0 | $0 |
| 2022-10 | 0 | $0 | 0 | $0 | 2,196 | $55 |
| 2022-06 | 0 | $0 | 2,500 | $14,444 | 0 | $0 |
| 2022-02 | 0 | $0 | 1,470 | $11,082 | 0 | $0 |
| 2021-04 | 1,477,057 | $25,109,969 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-14 | Orbimed Capital Gp Vi Llc | Sale | 168,136 | 15.88 | 2,670,840 |
| 2025-02-21 | Morrell Martha (CHIEF MEDICAL OFFICER) | Sale | 78,334 | 13.72 | 1,074,820 |
| 2025-02-20 | Kck Ltd. (10% Owner) | Sale | 5,270,845 | 9.40 | 49,545,943 |
| 2025-01-30 | Morrell Martha (CHIEF MEDICAL OFFICER) | Sale | 200 | 15.00 | 3,000 |
| 2025-01-29 | Morrell Martha (CHIEF MEDICAL OFFICER) | Sale | 100 | 15.00 | 1,500 |
| 2025-01-24 | Morrell Martha (CHIEF MEDICAL OFFICER) | Sale | 3,200 | 15.01 | 48,032 |
| 2024-10-25 | Kck Ltd. (10% Owner) | Sale | 223,991 | 5.45 | 1,220,974 |
| 2024-10-23 | Kck Ltd. (10% Owner) | Sale | 147 | 6.02 | 884 |
| 2024-10-22 | Kck Ltd. (10% Owner) | Sale | 4,082 | 6.09 | 24,855 |
| 2024-10-21 | Kck Ltd. (10% Owner) | Sale | 3,720 | 6.10 | 22,677 |
| 2024-10-18 | Kck Ltd. (10% Owner) | Sale | 4,878 | 6.29 | 30,692 |
| 2024-10-17 | Kck Ltd. (10% Owner) | Sale | 3,294 | 6.28 | 20,686 |
| 2024-10-16 | Kck Ltd. (10% Owner) | Sale | 6,900 | 6.57 | 45,339 |
| 2024-10-15 | Kck Ltd. (10% Owner) | Sale | 4,017 | 6.50 | 26,098 |
| 2024-10-14 | Kck Ltd. (10% Owner) | Sale | 4,031 | 6.54 | 26,358 |
| 2024-10-11 | Kck Ltd. (10% Owner) | Sale | 2,572 | 6.34 | 16,319 |
| 2024-10-10 | Kck Ltd. (10% Owner) | Sale | 2,504 | 6.12 | 15,316 |
| 2024-10-09 | Kck Ltd. (10% Owner) | Sale | 3,123 | 6.11 | 19,065 |
| 2024-10-08 | Kck Ltd. (10% Owner) | Sale | 6,000 | 6.42 | 38,550 |
| 2024-10-07 | Kck Ltd. (10% Owner) | Sale | 4,910 | 6.66 | 32,685 |
| 2024-10-04 | Kck Ltd. (10% Owner) | Sale | 5,757 | 6.92 | 39,832 |
| 2024-10-03 | Kck Ltd. (10% Owner) | Sale | 3,318 | 6.97 | 23,116 |
| 2024-10-02 | Kck Ltd. (10% Owner) | Sale | 3,843 | 6.87 | 26,401 |
| 2024-10-01 | Kck Ltd. (10% Owner) | Sale | 4,882 | 6.77 | 33,051 |
| 2024-09-30 | Kck Ltd. (10% Owner) | Sale | 4,749 | 6.73 | 31,960 |
| 2024-09-27 | Kck Ltd. (10% Owner) | Sale | 5,059 | 6.63 | 33,541 |
| 2024-09-26 | Kck Ltd. (10% Owner) | Sale | 5,821 | 6.62 | 38,535 |
| 2024-09-25 | Kck Ltd. (10% Owner) | Sale | 5,858 | 6.60 | 38,662 |
| 2024-09-23 | Kck Ltd. (10% Owner) | Sale | 282 | 7.54 | 2,126 |
| 2024-09-20 | Kck Ltd. (10% Owner) | Sale | 765 | 7.50 | 5,737 |
| 2024-09-13 | Kck Ltd. (10% Owner) | Sale | 1,993 | 7.59 | 15,126 |
| 2024-09-06 | Kck Ltd. (10% Owner) | Sale | 11 | 7.50 | 82 |
| 2024-09-04 | Kck Ltd. (10% Owner) | Sale | 14 | 7.50 | 105 |
| 2024-09-03 | Kck Ltd. (10% Owner) | Sale | 2,093 | 7.60 | 15,906 |
| 2024-08-30 | Kck Ltd. (10% Owner) | Sale | 4,314 | 7.76 | 33,476 |
| 2024-05-03 | Orbimed Capital Gp Vi Llc | Sale | 4,674 | 14.03 | 65,576 |
| 2024-05-02 | Orbimed Capital Gp Vi Llc | Sale | 8,842 | 14.01 | 123,876 |
| 2024-05-01 | Orbimed Capital Gp Vi Llc | Sale | 15,690 | 14.02 | 219,973 |
| 2024-04-24 | Orbimed Capital Gp Vi Llc | Sale | 1,781 | 14.06 | 25,040 |
| 2024-04-23 | Orbimed Capital Gp Vi Llc | Sale | 21,791 | 14.29 | 311,393 |
| 2024-04-22 | Orbimed Capital Gp Vi Llc | Sale | 24,609 | 14.05 | 345,756 |
| 2024-04-19 | Orbimed Capital Gp Vi Llc | Sale | 18,253 | 14.02 | 255,907 |
| 2024-04-18 | Orbimed Capital Gp Vi Llc | Sale | 2,623 | 14.06 | 36,879 |
| 2024-04-17 | Orbimed Capital Gp Vi Llc | Sale | 300 | 14.15 | 4,245 |
| 2024-04-16 | Orbimed Capital Gp Vi Llc | Sale | 14,069 | 14.01 | 197,106 |
| 2024-04-12 | Orbimed Capital Gp Vi Llc | Sale | 23,101 | 14.42 | 333,116 |
| 2024-04-11 | Orbimed Capital Gp Vi Llc | Sale | 461,899 | 14.49 | 6,692,916 |
| 2024-02-12 | Morrell Martha (CHIEF MEDICAL OFFICER) | Option Ex | 50,000 | .03 | 1,300 |
| 2024-02-05 | Morrell Martha (Chief Medical Officer) | Sale | 3,446 | 15.17 | 52,279 |
| 2024-02-02 | Morrell Martha (Chief Medical Officer) | Sale | 14,143 | 15.07 | 213,120 |
| 2024-02-01 | Morrell Martha (Chief Medical Officer) | Sale | 663 | 15.04 | 9,970 |
| 2024-01-31 | Morrell Martha (Chief Medical Officer) | Sale | 1,923 | 15.07 | 28,989 |
| 2024-01-31 | Morrell Martha (CHIEF MEDICAL OFFICER) | Option Ex | 52,810 | .03 | 1,373 |
| 2024-01-30 | Morrell Martha (Chief Medical Officer) | Sale | 11,262 | 15.10 | 169,999 |
| 2024-01-25 | Morrell Martha (Chief Medical Officer) | Sale | 1 | 15.00 | 15 |
| 2024-01-24 | Morrell Martha (Chief Medical Officer) | Sale | 827 | 15.03 | 12,425 |
| 2023-12-27 | Morrell Martha (Chief Medical Officer) | Sale | 13,300 | 10.12 | 134,649 |
| 2023-12-26 | Morrell Martha (Chief Medical Officer) | Sale | 102 | 10.00 | 1,020 |
| 2023-12-20 | Morrell Martha (Chief Medical Officer) | Sale | 2,730 | 10.14 | 27,695 |
| 2023-12-06 | Morrell Martha (Chief Medical Officer) | Sale | 11,005 | 8.16 | 89,778 |
| 2023-12-01 | Kck Ltd. (10% Owner) | Sale | 3,241 | 8.73 | 28,293 |
| 2023-11-30 | Kck Ltd. (10% Owner) | Sale | 7,282 | 8.84 | 64,372 |
| 2023-11-29 | Kck Ltd. (10% Owner) | Sale | 5,644 | 8.72 | 49,215 |
| 2023-11-28 | Kck Ltd. | Sale | 4,681 | 8.75 | 40,958 |
| 2023-11-27 | Kck Ltd. | Sale | 6,490 | 8.96 | 58,150 |
| 2023-10-03 | Orbimed Capital Gp Vi Llc | Sale | 700 | 9.02 | 6,314 |
| 2023-10-02 | Orbimed Capital Gp Vi Llc | Sale | 7,614 | 9.08 | 69,135 |
| 2022-11-22 | Accelmed Partners Ii L.p. (10% Owner) | Buy | 62,398 | 1.50 | 93,534 |
| 2022-11-21 | Accelmed Partners Ii L.p. (10% Owner) | Buy | 327,893 | 1.50 | 491,511 |
| 2022-10-31 | Kuhn Rebecca (Chief Financial Officer) | Option Ex | 1,428 | .03 | 37 |
| 2022-10-18 | Lacob Joseph (Director) | Option Ex | 192 | .03 | 4 |
| 2022-10-07 | Morrell Martha (Chief Medical Officer) | Option Ex | 576 | .03 | 14 |
| 2022-06-08 | Ridley Irina (General Counsel and Secretary) | Sale | 2,500 | 5.78 | 14,444 |
| 2022-02-28 | Ridley Irina (General Counsel and Secretary) | Sale | 1,470 | 7.54 | 11,082 |
| 2021-04-21 | Norton Evan (Director) | Buy | 588,235 | 17.00 | 9,999,995 |
| 2021-04-21 | Ridley Irina (General Counsel and Secretary) | Buy | 2,352 | 17.00 | 39,984 |
| 2021-04-21 | Accelmed Partners Ii L.p. (10% Owner) | Buy | 588,235 | 17.00 | 9,999,995 |
| 2021-04-21 | Orbimed Capital Gp Vi Llc (10% Owner) | Buy | 235,000 | 17.00 | 3,995,000 |
| 2021-04-21 | Garfield Greg Shaw (Director) | Buy | 13,235 | 17.00 | 224,995 |
| 2021-04-21 | Fischer Frank M (Director) | Buy | 50,000 | 17.00 | 850,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NPCE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neuropace Inc (symbol NPCE, CIK number 1528287) see the Securities and Exchange Commission (SEC) website.